Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (58)

2024

  1. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  2. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary, Vol. 27, Núm. 5, pp. 497-506

  3. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

2023

  1. Maximal Respiratory Pressure Reference Equations in Healthy Adults and Cut-off Points for Defining Respiratory Muscle Weakness

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 813-820

  2. Preconfigured analytical profiles for the management of patients with heart failure: a consensus-driven study

    REC: CardioClinics, Vol. 58, Núm. 3, pp. 219-227

2022

  1. Perfiles analíticos pre-configurados en insuficiencia cardiaca: implementación y uso en el Sistema Nacional de Salud Español

    Advances in Laboratory Medicine, Vol. 3, Núm. 1, pp. 71-78

  2. Specific test panels for patients with heart failure: Implementation and use in the Spanish National Health System

    Advances in Laboratory Medicine, Vol. 3, Núm. 1, pp. 65-70

2021

  1. Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 4, pp. 337-344

2020

  1. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 361-367

  2. Gender differences in health-related quality of life in patients with systolic heart failure: Results of the vida multicenter study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15

  3. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22

  4. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

    Cardiac Failure Review, Vol. 6

  5. RGD-dendrimer-poly(L-lactic) acid nanopatterned substrates for the early chondrogenesis of human mesenchymal stromal cells derived from osteoarthritic and healthy donors

    Materials, Vol. 13, Núm. 10

2019

  1. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus

    International Journal of Cardiology, Vol. 297, pp. 83-90

  2. Assessing Motivational Stages and Processes of Change for Weight Management Around Bariatric Surgery: a Multicenter Study

    Obesity Surgery, Vol. 29, Núm. 10, pp. 3348-3356

  3. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice-Vie-KinD study

    PLoS ONE, Vol. 14, Núm. 9

  4. PATJ Low Frequency Variants Are Associated with Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis

    Circulation Research, Vol. 124, Núm. 1, pp. 114-120

  5. Relevance of collaterals for the success of neuroprotective therapies in acute ischemic stroke: Insights from the randomized URICO-ICTUS Trial

    Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 171-177

2018

  1. Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

    European Journal of Heart Failure, Vol. 20, Núm. 7, pp. 1081-1099

  2. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522